Trade VRAX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Virax Biolabs Group Limited (VRAX) is trading at US$2.82, down 4.08% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$2.54M. Over the past 52 weeks, VRAX has traded between US$2.50 and US$21.75. On Syfe you can trade VRAX with $0 commission and add it to your watchlist.
| Previous close | US$2.94 |
|---|---|
| Market cap | US$2.54M |
| 52-week range | US$2.50 – US$21.75 |
| Volume | 36.04K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Virax Biolabs Group Limited
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Year: 2022
Top Midday Decliners
Jul 10, 6:06 PM · MT Newswires
Top Premarket Decliners
Jul 10, 11:35 AM · MT Newswires
Virax Biolabs to Implement 1-for-25 Share Consolidation
Jun 24, 2:51 PM · MT Newswires
Virax Biolabs Group Limited (VRAX) stock is trading at US$2.82, -4.08% from the previous close of US$2.94.
The market cap for Virax Biolabs Group Limited (VRAX) stock is approximately US$2.54M.
The 52-week high for Virax Biolabs Group Limited (VRAX) stock is US$21.75.
The 52-week low for Virax Biolabs Group Limited (VRAX) stock is US$2.50.
Virax Biolabs Group Limited (VRAX) does not currently pay a dividend.
Stay on top of VRAX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
